查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1654660

全球远距医疗市场 - 2025-2033

Global Telehealth Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球远距医疗市场规模达到 1,182.5 亿美元，预计到 2033 年将达到 6,999.5 亿美元，2025-2033 年预测期内的复合年增长率为 16.7%。

远距医疗是使用数位技术远端存取和管理医疗保健服务。家中个人或农村地区的医疗保健专业人员都可以使用它。医疗保健提供者还可以使用远距医疗来增强或支援医疗保健服务，例如使用电脑和行动装置进行远端存取或远端护理。

市场动态：

驱动因素与约束因素

远端患者监控需求不断增长

由于对远距病人监控的需求不断增加，全球远距医疗市场正在成长。随着糖尿病、心血管疾病和呼吸系统疾病等慢性疾病变得越来越普遍，医疗保健系统正在寻求有效的方法来提供持续的照护。远端病人监控使医疗保健提供者能够即时追踪患者的生命体征和健康资料，从而降低医疗保健成本并改善患者的治疗效果。老龄人口的不断增长以及穿戴式装置、行动健康应用和物联网技术的进步进一步增加了对远端监控解决方案的需求。

例如，2024年7月，TeleMedCare与美国一家顶级健康保险提供者合作推出了远距慢性病患者监测计划，涵盖五个州的50多万人。该计画位于佛罗里达州，旨在为 300 名患有慢性心臟、呼吸系统和代谢疾病（如充血性心臟衰竭、慢性阻塞性肺病、糖尿病和高血压）的患者提供治疗。该计划是 TeleMedCare 价值 20 亿美元的全球健康策略计划的一部分，重点是适应公司要求和协议。初步试验阶段将针对 300 名慢性病患者。

发展中地区缺乏健全的基础设施和有限的数位素养

由于发展中地区基础设施不足和数位素养有限，全球远距医疗市场面临挑战。网路连接不良、电信系统不发达以及智慧型设备存取阻碍了远距医疗的有效性。有限的数位素养也阻碍了采用。高成本和政府支持进一步阻碍了市场成长。需要对基础设施、技术和教育进行投资。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 远端患者监控需求不断增长
    • 限制
      • 发展中地区缺乏健全的基础设施和有限的数位素养
    • 机会
    • 影响分析

第五章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：按组件

  • 硬体
  • 软体
  • 服务

第 7 章：依交付方式

  • 本地部署
  • 基于云端

第 8 章：按应用

  • 慢性病管理
  • 心理健康与行为障碍
  • 放射科
  • 心臟病学
  • 神经病学
  • 皮肤科
  • 其他的

第 9 章：按最终用户

  • 医疗保健提供者
  • 患者
  • 付款人
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Teladoc Health, Inc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • American Well Corporation (Amwell)
  • MDLIVE Inc.
  • Doctor On Demand, Inc
  • Philips Healthcare
  • Medtronic plc
  • GE Healthcare
  • Siemens Healthineers AG
  • Epic Systems Corporation
  • Doximity
  • Similar data will be provided for each market player.
  • 巴比伦健康
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • K 健康
  • 他和她的健康公司
  • 我的文檔
  • 将为每个市场参与者提供类似的资料。

第 13 章：附录

简介目录
Product Code: HCIT9098

The Global Telehealth Market reached US$ 118.25 billion in 2024 and is expected to reach US$ 699.95 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033.

Telehealth is the use of digital technologies to access and manage healthcare services remotely. It can be used by individuals from home or by healthcare professionals in rural areas. Telehealth can also be used by healthcare providers to enhance or support healthcare services, such as using computers and mobile devices for remote access or remote care.

Market Dynamics: Drivers & Restraints

Rising Need for Remote Patient Monitoring

The global telehealth market is growing due to the increasing demand for remote patient monitoring. As chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders become more prevalent, healthcare systems are seeking efficient ways to provide continuous care. Remote patient monitoring allows healthcare providers to track patients' vital signs and health data in real-time, reducing healthcare costs and improving patient outcomes. The growing aging population and advancements in wearable devices, mobile health applications, and IoT technologies further increase the demand for remote monitoring solutions.

For instance, in July 2024, TeleMedCare launched a remote chronic patient monitoring program with a top health insurance provider in the U.S., covering over 500,000 people in five states. The program, based in Florida, aims to address 300 patients with chronic heart, respiratory, and metabolic conditions like CHF, COPD, diabetes, and hypertension. The program is part of TeleMedCare's two-billion-dollar global health strategy plan, focusing on adaptability to company requirements and protocols. The initial pilot phase is addressing 300 patients with chronic conditions.

Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions

The global telehealth market faces challenges due to inadequate infrastructure and limited digital literacy in developing regions. Poor internet connections, advanced telecommunications systems, and smart device access hinder telehealth effectiveness. Limited digital literacy also hinders adoption. High costs and government support further hinder market growth. Investments in infrastructure, technology, and education are needed.

Segment Analysis

The global telehealth market is segmented based on, Component, Delivery Mode, Application, End User and Region.

Product Type:

Hardware segment is expected to dominate the Telehealth market share

The hardware segment holds a major portion of the telehealth market share and is expected to continue to hold a significant portion of the telehealth market share during the forecast period.

Hardware is crucial in the global telehealth market, providing essential tools and devices for real-time data collection, analysis, and transmission between patients and healthcare providers. Advancements in hardware technology, such as portable diagnostic devices and IoT-enabled health monitoring gadgets, have improved the accuracy and accessibility of telehealth services. The integration of these devices with cloud platforms and mobile applications enhances the scalability of telehealth solutions, making them more efficient for patients and providers.

For instance, in November 2024, Thailand is introduced telehealth kiosks to modernize its healthcare system, allowing patients to measure vital signs like temperature, pulse, respiration, and blood pressure. The collected data is then transmitted to an online system for remote consultations with doctors. The 30-baht universal healthcare scheme allows patients to choose home delivery or pick up from participating pharmacies, aligning with the government's vision of expanding the service into a "30-baht anywhere" service, making quality healthcare more accessible and reducing hospital burden.

End User:-

Healthcare providers segment is the fastest-growing segment in Telehealth market share

The healthcare providers segment is the fastest-growing segment in the telehealth market share and is expected to hold the market share over the forecast period.

Healthcare providers are driving the global telehealth market by promoting virtual consultations, remote patient monitoring, and follow-up care. They build trust, educate patients about telehealth, and address privacy and usability concerns. Integrating telehealth into routine care reduces the burden on traditional facilities, especially in managing chronic diseases and emergency consultations. Active participation, supported by training programs and government incentives, is crucial in scaling telehealth adoption across different regions and demographics.

For instance, in June 2024, Apollo Telehealth and the Government of Manipur have launched a telemedicine-driven primary health center in Borobeka, Manipur, to improve healthcare access for communities affected by recent conflicts. The area, known for its isolation and challenging road conditions, faces significant obstacles to accessing timely medical care and emergency services. The nearest referral hospital is located 90 minutes away in Jiribam, causing prolonged treatment and health concerns.

Geographical Analysis

North America is expected to hold a significant position in the Telehealth market share

North America holds a substantial position in the telehealth market and is expected to hold most of the market share due to its, high adoption of digital health technologies, and focus on cost reduction. The region's high prevalence of chronic diseases like diabetes and cardiovascular disorders makes telehealth an ideal solution. Government policies, such as reimbursement for services and funding programs, encourage adoption. The widespread use of smartphones, high-speed internet, AI, and IoT also accelerates market growth.

For instance, in August 2024, Pfizer has launched PfizerForAll, a digital platform designed to simplify healthcare access and health management for Americans. The platform supports Billions affected by common illnesses like migraine, COVID-19, or flu, as well as those seeking adult vaccinations. It consolidates critical resources and services into a single destination, reducing the time and steps needed for important health actions like getting care, filling prescriptions, and finding potential savings on Pfizer medicines.

Europe is growing at the fastest pace in the Telehealth market

Europe holds the fastest pace in the telehealth market and is expected to hold most of the market share fueled by the need to improve healthcare access in rural areas and reduce the burden on overstretched systems. The aging population in countries like Germany, Italy, and the UK has increased the demand for remote patient monitoring and virtual consultations. The integration of digital technologies, government initiatives, and EHR adoption, along with advancements in telecommunication infrastructure, enhances the efficiency and accessibility of telehealth services.

For instance, Doctorsa, a global telehealth platform, has launched in the UK, connecting travellers with local doctors within five minutes. The platform, founded in Italy, has expanded internationally to 33 countries and has served over 100,000 users. Doctorsa connects tourists and UK residents seeking urgent care, especially those facing long waits for GP appointments or needing support outside surgery hours. The platform aims to meet the growing demand for accessible healthcare in the UK.

Competitive Landscape

The major global players in the telehealth market include Epic Systems Corporation, Oracle Corporation, Veradigm LLC, MEDITECH, McKesson Corporation, GE Healthcare, NXGN Management, LLC, Athenahealth, eClinicalWorks, Greenway Health and among others.

Key Developments

  • In August 2024, VSee Health, Inc. has launched its Aimee telehealth service in Wichita, Kansas, in partnership with Stand Together. Aimee offers virtual healthcare, labs, and prescription drugs to patients, regardless of health insurance. The service works with local community centres to transform them into centers of care, providing virtual urgent care, primary care, and medical weight loss with exercise programs to improve the health of residents in Wichita's communities.
  • In November 2024, MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, has introduced new Telehealth functionality within its MedAdvisor App. This feature was ranked as the third most desirable by pharmacists, according to feedback from its extensive network of pharmacy partners. Telehealth access simplifies the patient healthcare journey, allowing consultations with providers and prescription management from anywhere, at any time.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global telehealth market report delivers a detailed analysis with 70 key tables, more than 60 visually impactful figures, and 199 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Delivery Mode
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Need for Remote Patient Monitoring
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Robust Infrastructure and Limited Digital Literacy in Developing Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services

7. By Delivery Mode

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 7.1.2. Market Attractiveness Index, By Delivery Mode
  • 7.2. On-Premise*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cloud-based

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Chronic Disease Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Mental Health & Behavioral Disorders
  • 8.4. Radiology
  • 8.5. Cardiology
  • 8.6. Neurology
  • 8.7. Dermatology
  • 8.8. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Patients
  • 9.4. Payers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Teladoc Health, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. American Well Corporation (Amwell)
  • 12.3. MDLIVE Inc.
  • 12.4. Doctor On Demand, Inc
  • 12.5. Philips Healthcare
  • 12.6. Medtronic plc
  • 12.7. GE Healthcare
  • 12.8. Siemens Healthineers AG
  • 12.9. Epic Systems Corporation
  • 12.10. Doximity
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Babylon Health*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. K Health
  • 12.13. Hims & Hers Health, Inc
  • 12.14. MyDoc
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us